Your browser doesn't support javascript.
loading
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma.
Mouhieddine, Tarek H; Van Oekelen, Oliver; Melnekoff, David T; Li, Jeanne; Ghodke-Puranik, Yogita; Lancman, Guido; Thibaud, Santiago; Pan, Darren; Rajeeve, Sridevi; Agte, Sarita; Aleman, Adolfo; Sanchez, Larysa; Richard, Shambavi; Rossi, Adriana; Richter, Joshua; Cho, Hearn Jay; Rodriguez, Cesar; Lagana, Alessandro; Moshier, Erin; Chari, Ajai; Jagannath, Sundar; Parekh, Samir.
Affiliation
  • Mouhieddine TH; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Van Oekelen O; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Melnekoff DT; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Li J; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Ghodke-Puranik Y; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Lancman G; Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Thibaud S; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Pan D; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Rajeeve S; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Agte S; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Aleman A; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Sanchez L; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Richard S; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Rossi A; Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Richter J; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Cho HJ; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Rodriguez C; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Lagana A; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Moshier E; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Chari A; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Jagannath S; Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Parekh S; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
Blood Adv ; 7(6): 1056-1064, 2023 03 28.
Article in En | MEDLINE | ID: mdl-36018226

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Aged / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Limits: Aged / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article